Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

IO Biotech Q2 2024 GAAP EPS $(0.31) Beats $(0.35) Estimate, Cash Balance Of $100.7M Expected To Support Operations Into The Q4 Of 2025

Author: Benzinga Newsdesk | August 13, 2024 07:10am

Posted In: IOBT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist